Allergan, Inc. News Headlines

AGN 
$219.26
*  
3.13
1.41%
Get AGN Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Glaxo Announces EU Nod for Single-Pill HIV Drug Triumeq - Analyst Blog
9/8/2014 4:25:00 PM - Zacks.com


Novartis (NVS) Presents Positive Data on Ultibro Breezhaler - Analyst Blog
9/8/2014 4:05:00 PM - Zacks.com


Bayer/Regeneron Looking for Eylea Label Expansion in Japan - Analyst Blog
9/8/2014 3:45:00 PM - Zacks.com


Gilead Down on Likely Sovaldi Generic Deal in Poor Nations - Analyst Blog
9/8/2014 2:39:00 PM - Zacks.com


Abbott Labs' FreeStyle Libre Flash Glucose Gets CE Mark - Analyst Blog
9/5/2014 3:35:00 PM - Zacks.com


TSX Posts Smaller Loss Mid-Afternoon, Down 20 Points, As Energy Swings to Gain, Healthcare Rallies More Than 1%
9/5/2014 1:19:15 PM - MT Newswires


Merck's Anti-PD-1 Drug Keytruda First to be Launched in US - Analyst Blog
9/5/2014 10:20:00 AM - Zacks.com


Teva Wins Patent Litigation vs. AstraZeneca in UK - Analyst Blog
9/4/2014 4:50:00 PM - Zacks.com


Will AbbVie's $805 Million Agreement for Duvelisib Pay Off? - Analyst Blog
9/4/2014 4:10:00 PM - Zacks.com


Roche's Cobas 6800/8800 Testing Systems Launched - Analyst Blog
9/3/2014 5:55:00 PM - Zacks.com


Merck KGaA in Deal with S-TARget, Allergy Pipeline in Focus - Analyst Blog
9/3/2014 5:50:00 PM - Zacks.com


Sanofi Reports Positive Phase III Data on Dengue Vaccine - Analyst Blog
9/3/2014 5:40:00 PM - Zacks.com


Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead
9/3/2014 5:28:00 PM - Investor's Business Daily


Novo Nordisk Drops Anti-Inflammatory R&D Activities - Analyst Blog
9/3/2014 5:20:00 PM - Zacks.com


Bayer Discloses Encouraging Data on Anticoagulant Xarelto - Analyst Blog
9/3/2014 4:10:00 PM - Zacks.com


Misleading Statements In The Ruane, Cunniff, Goldfarb Annual Meeting Transcript Regarding Valeant And Allergan
9/3/2014 12:29:00 PM - Seeking Alpha


AstraZeneca Reports Data on Brilinta from ATLANTIC Study - Analyst Blog
9/2/2014 5:40:00 PM - Zacks.com


Bayer/Johnson & Johnson to Expand Xarelto Label Further - Analyst Blog
9/2/2014 5:30:00 PM - Zacks.com


Novartis Releases Positive Data on LCZ696 for Heart Failure - Analyst Blog
9/2/2014 4:10:00 PM - Zacks.com


UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog
9/2/2014 3:45:00 PM - Zacks.com


Prestige Brands to Sell Bonine for Insight Acquisition - Analyst Blog
9/2/2014 3:35:00 PM - Zacks.com


Novo Nordisk's Ryzodeg Now in Mexico for Type II Diabetes - Analyst Blog
9/2/2014 2:00:00 PM - Zacks.com


Glaxo Up on Accelerated Ebola Vaccine Development Process - Analyst Blog
9/2/2014 1:50:00 PM - Zacks.com


TSX Plunges Deeper Into the Red, Down 44 Points Mid-Afternoon, As Resource Stocks Continue to Decline
9/2/2014 1:15:59 PM - MT Newswires


TSX Down 21 Points at Midday As Resource Stocks Drag, But Healthcare Rally Limits Drop
9/2/2014 11:15:20 AM - MT Newswires